<DOC>
	<DOCNO>NCT02219997</DOCNO>
	<brief_summary>The purpose study compare reaction time ( measure brake reaction time second simulate drive ) glare no-glare condition subject implant ACRYSOF® IQ intraocular lens ( IOLs ) subject implanted clear IOLs . This study enroll subject previously implant IOLs eye least 3 month .</brief_summary>
	<brief_title>Functional Vision With ACRYSOF® IQ IOLs Blue Light Filtration</brief_title>
	<detailed_description>Subjects complete 2 visit investigational site .</detailed_description>
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Adrenocorticotropic Hormone</mesh_term>
	<mesh_term>Melanocyte-Stimulating Hormones</mesh_term>
	<mesh_term>beta-Endorphin</mesh_term>
	<mesh_term>Methamphetamine</mesh_term>
	<criteria>Pseudophakes ACRYSOF® IQ monofocal IOLs clear ( blue light filter ) IOLs eye least 3 month . Willing able understand sign inform consent form . Corrected visual acuity ( CVA ) 20/40 good . Have valid driver 's license . Depth perception least 100 arc second . Other protocolspecified inclusion criterion may apply . Ocular pathology , degeneration , medium opacity . Color vision defect . Use ocular systemic medication impact macular pigment density reaction time , include limited , lutein , zeaxanthin , barbiturate , tranquilizer amphetamine . System condition affect connective tissue sensorymotor coordination . Other protocolspecified exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Cataract</keyword>
	<keyword>Intraocular lens ( IOL )</keyword>
	<keyword>AcrySof</keyword>
</DOC>